Strategies for Reducing Risk of Elevated IRP

Dr Michelle Semins discusses strategies to minimize elevated intra-renal pressure, emphasizing the principle of ALARA (as low as reasonably achievable) by reducing inflow and increasing outflow, and suggesting tools and techniques such as stopcocks, gravity bags, ureter access sheaths, and new suction devices, while also highlighting the importance of controlling other risk factors like bacteria.

EP: 1.Overview of the Incidence, Diagnosis, and Treatment of Urinary Stones

EP: 2.The Evolving Role of Ureteroscopy in the Treatment of Urinary Stones

EP: 3.Overview of Intrarenal Pressure (IRP)

EP: 4.Potential Complications Seen in Patients With Elevated IRP

Now Viewing

EP: 5.Strategies for Reducing Risk of Elevated IRP

EP: 6.Key Treatment and Outcome Data for Patients Undergoing Therapy with Assistance of Ureteral Access Sheaths (UASs)

EP: 7.Factors for Consideration When Employing UASs In Patients With Urinary Stones

EP: 8.Methods for Continuous IRP Monitoring in Patients With Urinary Stones

EP: 9.Future Perspectives in the Treatment of Patients With Urinary Stones

Related Videos

Related Content

Advertisement

September 4th 2024

FDA grants rare pediatric disease designation to YOLT-203 for primary hyperoxaluria type 1

Hannah Clarke

YOLT-203 is currently being assessed in the early phase 1 YOLT-203-101 trial.

February 17th 2022

Why kidney stones will become more prevalent over time

Urology Times staff

“The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.

August 27th 2024

Increasing thiazide doses linked to fewer kidney stone events

Hannah Clarke

“What this means for patients is that thiazides remain an important option in the toolkit for preventing kidney stone recurrence,” says Ryan S. Hsi, MD, FACS.

September 9th 2021

Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

Urology Times staff

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

August 21st 2024

Data suggest Break Wave lithotripsy is safe, effective for urolithiasis

Hannah Clarke

Any stone fragmentation was achieved in 88% of patients.

August 19th 2024

Kari Tikkinen, MD, highlights the APPEAL trial of antibiotic prophylaxis prior to SWL

Urology Times staff

"The great news is that we have now completed recruitment. We actually recruited more than 1700 patients," says Kari A.O. Tikkinen, MD, PhD.

Related Content

Advertisement

September 4th 2024

FDA grants rare pediatric disease designation to YOLT-203 for primary hyperoxaluria type 1

Hannah Clarke

YOLT-203 is currently being assessed in the early phase 1 YOLT-203-101 trial.

February 17th 2022

Why kidney stones will become more prevalent over time

Urology Times staff

“The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.

August 27th 2024

Increasing thiazide doses linked to fewer kidney stone events

Hannah Clarke

“What this means for patients is that thiazides remain an important option in the toolkit for preventing kidney stone recurrence,” says Ryan S. Hsi, MD, FACS.

September 9th 2021

Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

Urology Times staff

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

August 21st 2024

Data suggest Break Wave lithotripsy is safe, effective for urolithiasis

Hannah Clarke

Any stone fragmentation was achieved in 88% of patients.

August 19th 2024

Kari Tikkinen, MD, highlights the APPEAL trial of antibiotic prophylaxis prior to SWL

Urology Times staff

"The great news is that we have now completed recruitment. We actually recruited more than 1700 patients," says Kari A.O. Tikkinen, MD, PhD.